Dr. Mark Cattral
Dr. Mark Cattral is a Professor of Surgery, the Director of the Pancreas Transplantation Program, and a Sr. Scientist at the University Health Network, University of Toronto. Dr. Cattral’s laboratory is investigating dendritic cell biology and strategies to induce transplantation tolerance. Recent discoveries from his laboratory have contributed to the current understanding of dendritic cell ontogeny and function of immediate dendritic cell precursors.
Dr. Steven Gallinger
Dr. Steven Gallinger is an Hepatobiliary/pancreatic (HPB) surgical oncologist and member of the GI Site Cancer Program at Princess Margaret Cancer Centre. He is Professor of Surgery at the University of Toronto and Chair of the Cancer Care Ontario HPB Community of Practice. His research interests are primarily in the area of GI cancer genetics and he is co-Director of the Centre for Cancer Genetics at the Samuel Lunenfeld Research Institute, and co-PI of the Zane Cohen Familial Gastrointestinal Cancer Registry at MSH. He is also PI of the Ontario Pancreas Cancer Study, a member of the NIH funded Pancreas Cancer Genetic Epidemiology consortium, a population-based registry of pancreas cancer cases and their families which is now integrated with the International Cancer Genome Consortium at the OICR where he is Head of the Translational Research Initiative in pancreas cancer, termed PanCuRx. Dr. Gallinger also co-leads (with Dr. Jennifer Knox) the McCain Centre for Pancreas Cancer which supports the rapid diagnostic and treatment program at UHN.
Dr. Anand Ghanekar
Dr. Anand Ghanekar, MD PhD, is an attending surgeon in the Division of General Surgery at the University Health Network and Hospital for Sick Children, and Assistant Professor of Surgery at the University of Toronto. Dr. Ghanekar’s clinical practice is focused on abdominal organ transplantation in adults and children. He is Co-Director of the Kidney Transplant Program at the University Health Network. Dr. Ghanekar’s research laboratory studies stem cells in the context of hepatocellular carcinoma as well as developmental liver diseases.
Dr. Ian McGilvray
Dr. Ian McGilvray studied medicine at McGill University, graduating in 1993. He entered the General Surgery training program at the University of Toronto that same year. During his residency he undertook graduate studies in Dr. Ori Rotstein’s laboratory, and obtained a PhD in Cell Biology. He became a Fellow of the Royal College of Physicians and Surgeons of Canada in 2001. After a clinical fellowship in Transplantation and Hepatobiliary Surgery at Toronto General Hospital, he began his appointment at University Health Network in 2003. He currently leads the HPB Surgical Oncology Program at UHN and is a Professor in the Department of Surgery at the University of Toronto. His clinical focus is devoted to transplantation and to complex liver and pancreas oncology. His research centers on diseases of the liver, and includes research in viral hepatitis and nanomedicine.
Dr. Carol-anne Moulton
Dr. Carol-anne Moulton graduated from The University of Melbourne, Melbourne, Australia in 1992 and completed general surgical training earning certification from the Royal Australasian College of Surgeons in 2001. She undertook several Fellowships following this including a Fellowship in Upper Gastrointestinal and Laparoscopic Surgery at St. Vincents Hospital in Melbourne, a Fellowship in Hepato-Pancreatico-Biliary (HPB) Surgery at Toronto General Hospital, and a Surgical Education Fellowship at the University of Toronto, earning a Master’s of Higher Education in 2006 and a PhD in 2010. She is an Associate Professor in the Department of Surgery and Co-Director of the HPB Fellowship Program at the University of Toronto, and the Medical Director of the Operating Room at Toronto General Hospital. In early 2010, Dr. Moulton became a Scientist at the Wilson Centre at the University of Toronto, and she is the recipient of the Early Researcher Award from the Ministry of Research and Innovation. Her research has been supported by the Medical Council of Canada, the Royal College of Physicians and Surgeons of Canada, and Physicians’ Services Incorporated. Dr. Moulton’s research program focuses on understanding the complexity of surgical judgement, the development of surgical expertise, and underlying causes of surgeon error.
Dr. Trevor Reichman
Dr. Trevor Reichman completed his residency in General Surgery at the University of Chicago Medical Center and subsequently performed a fellowship in Abdominal Organ Transplantation and HPB Surgery in Toronto between 2009 and 2011. Following his Fellowship, Dr. Reichman moved to the Ochsner Medical Center in New Orleans, Louisiana were he assumed the role of Co-Director of Living Donor Liver Transplantation and Pediatric Liver Transplantation. He also started and was the Director of the Abdominal Transplant Fellowship at Ochsner. After 5 years, he relocated to Virginia Commonwealth University in Richmond, Virginia where he was the Surgical Director of Liver Transplantation and the Director of Pediatric Liver Transplantation. In 2019 he returned to the Division of General Surgery and the UHN Transplant Program at TGH as a new member of the Abdominal Organ Transplant and HPB Surgery team, Director of the HPB/Surgical Transplant Fellowship, and Director of the Surgical Pancreas Program. His research interests include Quality Improvement in Transplantation and racial disparities in outcomes from hepatocellular cancer.
Dr. Gonzalo Sapisochin
Dr. Gonzalo Sapisochin graduated from the Medical School at the Universidad Complutense de Madrid, Spain, in 2005 and went on to complete his general surgery residency at the Hospital Universitario Vall d´Hebron, Barcelona, Spain in 2011. During his residency, he spent time in the USA, at both Jackson Memorial in Miami, and the University of California in San Francisco. In 2011 he also completed his doctoral thesis at the Universidad Autonoma of Barcelona.
From 2011 to 2013, he was employed as a staff surgeon at the Hospital Universitario Vall d´Hebron, in the Department of HPB Surgery and Transplantation.
In 2014, he began his Abdominal Transplant & HPB Surgical Oncology Fellowship at the University of Toronto, which he completed December 2015. As of January 1, 2016, he became a Staff Surgeon at the Toronto General Hospital, and an Assistant Professor in the Department of Surgery, at the University of Toronto. In the winter of 2016 he spearheaded the creation of the Toronto Liver Cancer Research group, for which he is PI. Most recently, he has taken on the role of Fellowship Research Director, for the HPB/Surgical Transplant Fellowships.
Dr. Markus Selzner
Dr. Markus Selzner graduated from the Medical School at the University of Münster, Germany, in 1993 and started his residency at the Department of Surgery at the University of Cologne between 1994 and 1997. In 1997, he went to the Duke University Medical Center in North Carolina for a three-year research fellowship focusing on hepatic reperfusion injury. In 2000, Dr. Selzner continued his residency at the Department of Visceral and Transplantation Surgery at the University Hospital of Zurich, Switzerland, and was board certiﬁed in Surgery in 2002. He completed a fellowship in Liver/Pancreas Surgery and Liver Transplantation in Zürich between 2003 and 2005, and was appointed Assistant Professor of Surgery and Surgical Attending at the University of Zurich in 2003. Between 2005 and 2007 Dr. Selzner completed an Abdominal Organ Transplant Fellowship at the Toronto General Hospital in Toronto, Canada, and was appointed Clinical Associate in 2007. In July 2009 Dr. Selzner was appointed Associate Professor of Surgery at the University of Toronto. Dr. Selzner is the current Program Co-Director (and past PD) of the Abdominal Organ Transplant Fellowship and he is also the Surgical Director of Liver Transplant at UHN.